Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home
 
Publications
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
Vaccines: Yaugel-Novoa M., Noailly B., Jospin F., Berger A.E., Waeckel L., Botelho-Nevers E., Longet S., Bourlet T., Paul S. https://www.mdpi.com/2076-393X/11/4/773
The Lancet Microbe: Yaugel-Novoa M., Bourlet T., Longet S., Botehlo-Nevers E, Paul S. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00095-2/fulltext
Moreews M ; Mathieu AL, Pouxvielh K... Marçais A, Walzer T, Belot A
Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO.
 
Actualités
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
New publication - VIV Team in Nature communication
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
Several CIRI teams carried out this work, published in the journal Science Translational Medicine.
Nous rejoindre
Le/la gestionnaire administratif(ve) et financier(e) est chargé(e) d’assurer des fonctions polyvalentes au sein du service gestion administration du CIRI. Il/elle effectue des actes de gestion aux bénéfices des équipes de recherche et services communs du centre dans le respect des règles et procédures applicables au domaine de la gestion financière publique.
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
A post-doctoral position in Immuno-Therapy is open in EVIR Team
Agenda
Innate sensors and Inflammation meeting: New date September 5th-7th! Still in Lyon, France!
"Decoding the battle between Mycobacterium tuberculosis and host metal defenses"
"Inter-organ communication in host defense"
 « Bacterial immunity as a source of novel antiviral mechanisms across the tree of life »
New publication - VIV Team in Nature communication
« Entry of human paramyxoviruses: The first step » &  « Enveloped Virus Entry Mechanisms: Past, Present and Future »